Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Self

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Biometrics|March 1, 1989
On testing departure from the binomial and multinomial assumptionsS R Paul, K Y Liang, S G Self
Biometrics|September 1, 1990
The Cox proportional hazards model with change point: an epidemiologic applicationK Y Liang, S G Self, X H Liu
Statistical Methods in Medical Research|April 8, 2004
Endpoints in vaccine trialsMichael G Hudgens, Peter B Gilbert, Steven G Self
Biometrics|September 29, 1998
Statistical methods for assessing differential vaccine protection against human immunodeficiency virus typesP B Gilbert, S G Self, M A Ashby
Plos Computational Biology|June 23, 2006
On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trialsW David Wick, Peter B Gilbert, Steven G Self
Statistics in Medicine|September 1, 1989
Further results on covariate measurement errors in cohort studies with time to response dataM S Pepe, S G Self, R L Prentice
The American Journal of Medicine|November 1, 1986
Failure to diagnose anemia in medical inpatients. Is the traditional diagnosis of anemia a dying art?K G Self, M M Conrady, E R Eichner
Neuroscience|April 1, 1993
Exogenously administered alpha-bungarotoxin binds to embryonic chick spinal cord: implications for the toxin-induced arrest of naturally occurring motoneuron deathG Renshaw, P Rigby, G Self, et al.
Journal of Virology|October 18, 2005
How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?W David Wick, Otto O Yang, Lawrence Corey, et al.
Biometrics|March 1, 1991
On estimating HLA/disease association with application to a study of aplastic anemiaS G Self, G Longton, K J Kopecky, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Biometrics|March 1, 1989
On testing departure from the binomial and multinomial assumptionsS R Paul, K Y Liang, S G Self
Biometrics|September 1, 1990
The Cox proportional hazards model with change point: an epidemiologic applicationK Y Liang, S G Self, X H Liu
Statistical Methods in Medical Research|April 8, 2004
Endpoints in vaccine trialsMichael G Hudgens, Peter B Gilbert, Steven G Self
Biometrics|September 29, 1998
Statistical methods for assessing differential vaccine protection against human immunodeficiency virus typesP B Gilbert, S G Self, M A Ashby
Plos Computational Biology|June 23, 2006
On modeling HIV and T cells in vivo: assessing causal estimators in vaccine trialsW David Wick, Peter B Gilbert, Steven G Self
Statistics in Medicine|September 1, 1989
Further results on covariate measurement errors in cohort studies with time to response dataM S Pepe, S G Self, R L Prentice
The American Journal of Medicine|November 1, 1986
Failure to diagnose anemia in medical inpatients. Is the traditional diagnosis of anemia a dying art?K G Self, M M Conrady, E R Eichner
Neuroscience|April 1, 1993
Exogenously administered alpha-bungarotoxin binds to embryonic chick spinal cord: implications for the toxin-induced arrest of naturally occurring motoneuron deathG Renshaw, P Rigby, G Self, et al.
Journal of Virology|October 18, 2005
How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?W David Wick, Otto O Yang, Lawrence Corey, et al.
Biometrics|March 1, 1991
On estimating HLA/disease association with application to a study of aplastic anemiaS G Self, G Longton, K J Kopecky, et al.
Pageof 13